23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.73%
Revenue growth exceeding 1.5x Insurance - Life median of 4.04%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
9.73%
Gross profit growth exceeding 1.5x Insurance - Life median of 4.94%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
-10.01%
Negative EBIT growth while Insurance - Life median is 4.55%. Seth Klarman would check if external or internal factors caused the decline.
-10.01%
Negative operating income growth while Insurance - Life median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
0.08%
Net income growth of 0.08% while Insurance - Life median is zero. Walter Schloss might see potential if moderate gains can keep rising.
0.07%
EPS growth below 50% of Insurance - Life median of 1.43%. Jim Chanos would suspect fundamental earnings weakness or heavy dilution.
0.10%
Diluted EPS growth below 50% of Insurance - Life median of 1.43%. Jim Chanos would suspect fundamental profit weaknesses or heavy share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.99%
OCF growth of 7.99% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
7.99%
FCF growth of 7.99% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
168.00%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 84.64%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
137.26%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 60.35%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
30.13%
3Y revenue/share growth near Insurance - Life median of 27.97%. Charlie Munger would note typical industry expansions over the short term.
127.92%
OCF/share CAGR of 127.92% while Insurance - Life median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
99.24%
OCF/share CAGR of 99.24% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
2.29%
3Y OCF/share growth of 2.29% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
337.47%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 178.64% over a decade. Joel Greenblatt might see a standout compounder of earnings.
190.16%
5Y net income/share CAGR > 1.5x Insurance - Life median of 103.49%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
42.52%
3Y net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm expansions or margin boosts drive the short-term advantage.
237.44%
Equity/share CAGR of 237.44% while Insurance - Life median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
178.18%
5Y equity/share CAGR > 1.5x Insurance - Life median of 48.03%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
3.80%
Below 50% of Insurance - Life median. Jim Chanos worries about inadequate short-term profitability or repeated asset impairments.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
0.33%
Asset growth of 0.33% while Insurance - Life median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
0.94%
Near Insurance - Life median. Charlie Munger considers it standard net worth compounding for the sector.
-22.86%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
7.38%
SG&A growth of 7.38% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.